The microbial coinfection in COVID-19
Xi Chen1,2, Binyou Liao1, Lei Cheng1,2
1State Key Laboratory of Oral Diseases & National Clinical Research Center for Oral Diseases, Sichuan University, NO. 14, 3rd Section of Ren Min Nan Rd. Chengdu, Sichuan, 610041, China.
Microbial coinfection significantly impacts coronavirus disease 2019 (COVID-19) severity and outcomes. Understanding these coinfections is crucial for improving diagnosis, treatment, and prognosis in patients with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Area of Science:
- Infectious Diseases
- Virology
- Microbiology
Background:
- Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) causes COVID-19, posing a global health challenge, particularly for the elderly.
- Microbial coinfections, including viral, bacterial, and fungal, are increasingly recognized as significant factors in COVID-19 pathogenesis.
- These coinfections complicate diagnosis, treatment, and prognosis, potentially increasing disease severity and mortality.
Purpose of the Study:
- To review the role of microbial coinfections in COVID-19.
- To analyze the impact of coinfections on disease development and outcomes.
- To highlight the importance of diagnosing and managing coinfections in SARS-CoV-2 patients.
Main Methods:
- Literature review and synthesis of existing studies on microbial coinfections in COVID-19.
- Analysis of coinfection types (viral, bacterial, fungal) with SARS-CoV-2.
- Examination of the effects of coinfections on clinical presentation, diagnosis, and prognosis.
Main Results:
- Microbial coinfection is a common and critical factor in COVID-19.
- Coinfections exacerbate COVID-19, leading to more severe symptoms and poorer outcomes.
- Various pathogens, including viruses, bacteria, and fungi, have been identified as coinfecting agents with SARS-CoV-2.
Conclusions:
- Microbial coinfection is a non-negligible factor in COVID-19, influencing disease progression and patient outcomes.
- Coinfections present significant challenges in clinical diagnosis and treatment strategies for COVID-19.
- Comprehensive diagnostic approaches are essential to identify and manage microbial coinfections in SARS-CoV-2 infected individuals.
Related Concept Videos
Factors Affecting the Risk of Infection
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
Healthcare Associated Infections I: Iatrogenic, Exogenic and Endogenic
HAIs significantly increase the cost of health care. Extended stays in healthcare institutions, increased disability, increased costs of medications, including specialized antibiotics, and prolonged recovery times add to the patient's expenses and the healthcare institution and funding bodies.
Pneumonia II: Pathophysiology
Viral Recombination
Pneumonia III: Complications and Assessment
Infection
The chain begins with pathogens: bacteria, viruses, fungi, prions, or parasites such as protozoa helminths. These can be present on the skin as transient or resident flora, or they can be acquired from the environment. Identifying and treating the type of infection and...


